Difference between revisions of "Section 2: IFNs as natural broad-spectrum antivirals (from DOI: 10.1084/jem.20200653) (Q11179)"
Jump to navigation
Jump to search
Latest revision as of 19:32, 24 June 2020
Publication: "COVID-19 and emerging viral infections: The case for interferon lambda"published as J. Exp. Med.; 2020 05 04 ; 217 (5); DOI: 10.1084/jem.20200653
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Section 2: IFNs as natural broad-spectrum antivirals (from DOI: 10.1084/jem.20200653)
|
Publication: "COVID-19 and emerging viral infections: The case for interferon lambda"published as J. Exp. Med.; 2020 05 04 ; 217 (5); DOI: 10.1084/jem.20200653
|
Statements
0 references
